Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Share-based Compensation: 2019-2024

Historic Share-based Compensation for Cellebrite DI (CLBT) over the last 6 years, with Dec 2024 value amounting to $30.6 million.

  • Cellebrite DI's Share-based Compensation rose 35.49% to $7,983 in Q2 2025 from the same period last year, while for Jun 2025 it was $30,596, marking a year-over-year decrease of 99.38%. This contributed to the annual value of $30.6 million for FY2024, which is 176992.38% up from last year.
  • Cellebrite DI's Share-based Compensation amounted to $30.6 million in FY2024, which was up 176,992.38% from $17,265 recorded in FY2023.
  • Over the past 5 years, Cellebrite DI's Share-based Compensation peaked at $30.6 million during FY2024, and registered a low of $17,265 during FY2023.
  • Its 3-year average for Share-based Compensation is $14.8 million, with a median of $13.7 million in 2022.
  • As far as peak fluctuations go, Cellebrite DI's Share-based Compensation slumped by 99.87% in 2023, and later surged by 176,992.38% in 2024.
  • Cellebrite DI's Share-based Compensation (Yearly) stood at $7.3 million in 2020, then dropped by 10.88% to $6.5 million in 2021, then surged by 111.54% to $13.7 million in 2022, then plummeted by 99.87% to $17,265 in 2023, then spiked by 176,992.38% to $30.6 million in 2024.